Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NCI/V-A clinical trial agreement gives eligible veterans coverage for NCI studies.

Executive Summary

NATIONAL CANCER INSTITUTE/VETERANS AFFAIRS CLINICAL TRIAL AGREEMENT signed during the week of Oct. 14-18 will cover eligible veterans for "the full range of NCI-sponsored studies in diagnosis, treatment and prevention." The three-year demonstration agreement, signed by NCI Director Richard Klausner, MD, and Department of Veterans Affairs Undersecretary for Health Kenneth Kizer, MD, takes effect Jan. 1.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS029052

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel